| Metric | სს ბიოფარმი | სს საქართველოს ნავთობისა და გაზის კორპორაცია |
|---|---|---|
| Growth | ||
| Revenue | ₾10.1m₾9.7m | ₾1.65bn₾1.40bn |
| Revenue growth | 4.8% | 17.4% |
| Profitability | ||
| EBITDA | -₾847k-₾427k | ₾247.6m₾130.7m |
| EBITDA margin | -8.3%-4.4% | 15.0%9.3% |
| Net profit | -₾1.3m-₾1.1m | ₾183.4m₾50.1m |
| Net margin | -12.6%-11.5% | 11.1%3.6% |
| Balance sheet | ||
| Total assets | ₾19.1m₾18.5m | ₾2.19bn₾2.04bn |
| Total equity | ₾18.2m₾17.1m | ₾1.32bn₾1.14bn |
| ROE | -7.0%-6.5% | 13.9%4.4% |